INHIBITION OF INFLUENZA-VIRUS REPLICATION IN MICE BY GG167 ANIDINO-2,4-DIDEOXY-2,3-DEHYDRO-N-ACETYLNEURAMINIC ACID) IS CONSISTENT WITH EXTRACELLULAR ACTIVITY OF VIRAL NEURAMINIDASE (SIALIDASE)
Dm. Ryan et al., INHIBITION OF INFLUENZA-VIRUS REPLICATION IN MICE BY GG167 ANIDINO-2,4-DIDEOXY-2,3-DEHYDRO-N-ACETYLNEURAMINIC ACID) IS CONSISTENT WITH EXTRACELLULAR ACTIVITY OF VIRAL NEURAMINIDASE (SIALIDASE), Antimicrobial agents and chemotherapy, 38(10), 1994, pp. 2270-2275
We demonstrate the potent antiviral activity of a novel viral neuramin
idase (sialidase) inhibitor, anidino-2,4-dideoxy-2,3-dehydro-N-acetyln
euraminic acid (GG167), administered by the intranasal route in compar
ison with those of amantadine and ribavirin in experimental respirator
y tract infections induced with influenza A and B viruses. In an exten
ded study in which mice were infected (day 0) with influenza A/Singapo
re/1/57 virus, with treatments given prophylactically plus twice daily
over days 0 to 3 and with mice observed to day 10, we show that intra
nasally administered GG167 at 0.4 and 0.01 mg/kg of body weight per do
se reduced mortality, lung consolidation, and virus titers in the lung
, with no virus growing back following the cessation of treatment. In
other studies with influenza B/Victoria/102/85 virus in which infected
mice were culled after the cessation of treatment, the calculated int
ranasal dose required to reduce virus titers in the lungs of treated a
nimals to 10% of that seen in untreated controls (ED(AUC10) [where AUC
is area under the virus titer days curve]) was 0.085 mg/kg per dose.
GG167 was inactive against influenza viruses A and B when given by the
intraperitoneal or oral route (ED(AUC10), > 100 mg/kg per dose). GG16
7 was metabolically stable, with an elimination half-life of 10 min fo
llowing intravenous administration. While readily bioavailable by syst
emic routes, it was poorly bioavailable by the oral route. Its potent
efficacy by the intranasal route but lack of efficacy by other routes,
relative to those of amantadine and ribavirin, was explicable in term
s of its in vitro activity, bioavailability, and pharmacokinetic prope
rties and with the extracellular activity of viral sialidase.